Speaker Details

Ruth Ann Vleugels, MD, MBA, MPH, FAAD

Ruth Ann Vleugels, MD, MBA, MPH, FAAD

Penn Medicine

BIOGRAPHY

Since September 1st, 2026, Ruth Ann Vleugels, MD, MPH, MBA has transitioned to serve as Chair and Professor of Dermatology at Penn Medicine. Until recently, she was Professor of Dermatology at Harvard Medical School, the Heidi and Scott C. Schuster Distinguished Chair in Dermatology at Brigham and Women’s Hospital, and Associate Chief Operating Officer at Mass General Brigham, where she led Medical and Oncologic Infusion Operations and Strategy and co-led Virtual Care Operations for MGB’s 11 member hospitals. She was Founding Director of the Autoimmune Skin Disease Program, Myositis Center, Connective Tissue Disease Clinics, and Atopic Dermatitis Program at Brigham and Women’s Hospital and Co-Director of the Rheumatology-Dermatology Program at Boston Children’s Hospital. Dr. Vleugels developed the MGB Dermatology-Rheumatology Fellowship, the first fellowship opportunity of its kind nationally, which has now transitioned to Penn. She has been selected for Harvard Medical School’s most prestigious clinical expertise, teaching, and mentoring awards and is Past President of both the New England Dermatologic Society and Rheumatologic Dermatology Society as well as a recent member of the Board of Directors of the American Academy of Dermatology. An international expert in autoimmune connective tissue diseases, Dr. Vleugels’ clinical research focuses on rare autoimmune skin diseases and emerging medical therapies.

SESSIONS

S055 What’s Hot in Autoimmune Connective Tissue Disease
Mar 22, 2027 • 1:00 PM - 4:00 PM
S052 Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
Mar 22, 2027 • 1:00 PM - 4:00 PM

DISCLOSURES

AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); Biogen – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);